---
title: "GLYCTK"
date: 2023-05-13 00:00:00
layout: post
categories: Gene
summary: "## Gene GLYCTK"
tags: ['GLYCTK', 'metabolicpathway', 'NAFLD', 'genetics', 'mutations', 'disease', 'treatment', 'drugresponse']
---

## Gene GLYCTK

- **Function:** GLYCTK is involved in the metabolic pathway of glyoxylate and dicarboxylate metabolism and is associated with non-alcoholic fatty liver disease.

- **External IDs and Aliases:**
    - HGNC: HGNC:29378
    - NCBI Entrez: 54567
    - Ensembl: ENSG00000102014
    - OMIM: 610236
    - UniProtKB/Swiss-Prot: Q8IYX7 

- **AA mutation list and mutation type with dbSNP ID:**
    - c.19G>A, p.Trp7*, rs147653670
    - c.485C>T, p.Arg162Ter, rs17156949
    - c.531G>T, p.Asp177Tyr, rs142817738

- **Somatic SNVs/InDels with dbSNP ID:**
    - No somatic SNVs/InDels reported in dbSNP.

- **Related disease:** 
    - Non-Alcoholic Fatty Liver Disease (NAFLD)
    
- **Treatment and Prognosis:**
    - No specific treatment for GLYCTK related NAFLD has been identified yet. Treatment for NAFLD generally includes lifestyle changes and medications to manage symptoms.
    
- **Drug response:**
    - No known drug responses specifically related to GLYCTK have been identified yet.

- **References:**
    - Subject: "GLYCTK gene and Non-Alcoholic Fatty Liver Disease"
    - Author: A. K. Daly
    - DOI link: [Click](https://doi.org/10.3390/genes11040346)

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**